Q&A: AstraZeneca CIO Cindy Hoots on Covid-19, collaboration — and change

Over the past two years, Swedish-English pharmaceutical company AstraZeneca has been at the heart of the response to the COVID-19 pandemic, developing a vaccine and supplying more than 2.5 billion doses to people in 170 countries.Like most organizations, it was forced to shift rapidly to a remote-work model for many of its 70,000 employees when the pandemic struck in March 2020. Connecting a range of workers, including lab staff, was vital to maintaining operations during what was an unpreceden